Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.41 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | RAB9A | P51151 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19166745 | 0.96 | NPC1 (0.41) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165455 | 0.95 | RAB9A (0.41) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165168 | 0.94 | HSD17B10 (0.42) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19166528 | 0.94 | PLA2G2A (0.40) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL15501282 | 0.93 | KDM4E (0.44) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165761 | 0.92 | HSD17B10 (0.42) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165167 | 0.92 | HSD17B10 (0.44) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165244 | 0.91 | HSD17B10 (0.43) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165401 | 0.91 | HSD17B10 (0.43) | PLA2G2APLA2G4APLA2G10NPC1MAPT | |
| SCHEMBL19165127 | 0.91 | HSD17B10 (0.43) | PLA2G2APLA2G4APLA2G10NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10784446-B2 | Compound, organic electroluminescence element material, organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2020-09-22 | — | — | US | disclosed |
| US-20170213983-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20170213983-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10784446-B2 | Compound, organic electroluminescence element material, organic electroluminescence element and electronic device | L1CAM, SOD1, OR10J3 | PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885 |
| US-20170213983-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | L1CAM, SOD1, OR10J3 | PLA2G2A 3552/4885PLA2G4A 4204/4885PLA2G10 2607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.